Rozov Yadin 4

What Happened
Rozov Yadin, a director of Core Scientific, received a grant of 18,575 restricted stock units (RSUs) on February 4, 2026. The RSUs were issued at $0.00 per share (typical for awards), so there were no immediate cash proceeds. The award will vest in full on February 3, 2027, subject to continued service as a non‑employee director.

Key Details

• Transaction date and price: 2026-02-04; acquisition price reported as $0.00.
• Securities granted: 18,575 RSUs (reported as an Award/Grant, code A).
• Shares owned after transaction: Not specified in the filing.
• Footnote: F1 — RSUs vest in full on Feb 3, 2027 if Reporting Person continues service as a non‑employee director.
• Filing: Form 4 filed 2026-02-06 reporting the 2026-02-04 grant (appears timely).

Context
RSU grants are a form of compensation, not an open‑market purchase or sale; they do not represent immediate cash value until vested and settled. Because vesting is tied to continued service, these awards can be forfeited if the director leaves before the vest date. This filing reports the grant only and does not indicate any immediate trading or cashless exercise.